On March 29, 2012, the Food and Drug Administration (FDA) issued a recall of GranuFlo and NaturaLyte. These products were manufactured by Fresenius Medical Care and were used to treat kidney disease and kidney failure. According to the FDA, the use of these products could lead to low blood pressure and cardiac arrhythmia.
Fresenius was aware of these dangers, but did not share that information with health care providers or consumers. These products were used in numerous dialysis facilities, not just those owned by Fresenius.
Several hundred cases involving GranuFlo and NaturaLyte have been consolidated into Multi-District Litigation in the United States District Court for the District of Massachusetts.
If you or a loved one has experienced a sudden cardiac event during or soon after dialysis treatment, please give us a call to learn more about your legal rights.
Teresa E. Harvey
